Craneware plc (AIM: CRW)
London
· Delayed Price · Currency is GBP · Price in GBX
2,026.00
-24.00 (-1.17%)
Jan 21, 2025, 2:18 PM GMT+1
Craneware Revenue
Craneware had revenue of $91.21M USD in the half year ending December 31, 2024, with 7.73% growth. This brings the company's revenue in the last twelve months to $195.81M, up 8.45% year-over-year. In the fiscal year ending June 30, 2024, Craneware had annual revenue of $189.27M with 8.76% growth.
Revenue (ttm)
$195.81M
Revenue Growth
+8.45%
P/S Ratio
4.54
Revenue / Employee
$262.13K
Employees
747
Market Cap
714.37M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 189.27M | 15.25M | 8.76% |
Jun 30, 2023 | 174.02M | 8.47M | 5.12% |
Jun 30, 2022 | 165.54M | 89.97M | 119.04% |
Jun 30, 2021 | 75.58M | 4.09M | 5.72% |
Jun 30, 2020 | 71.49M | 91.00K | 0.13% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |